Flash forward: a review of flash glucose monitoring
- 27 February 2018
- journal article
- review article
- Published by Wiley in Diabetic Medicine
- Vol. 35 (4) , 472-482
Abstract
The FreeStyle Libre flash glucose monitor became available on prescription (subject to local health authority approval) in all four nations of the UK from November 2017, a watershed moment in the history of diabetes care. Calibration free, the FreeStyle Libre is a disc worn on the arm for 14 days which is designed largely to replace the recommended 4–10 painful finger‐stick blood glucose tests required each day for the self‐management of diabetes. This review discusses clinical data from randomized and observational studies, considers device accuracy metrics and deliberates its popularity and the potential challenges that this new device brings to diabetes care in the UK. In randomized trials, FreeStyle Libre use is associated with a reduction in hypoglycaemia and, in observational studies, improvements in HbA1c levels. User satisfaction is high and adverse events are low. Accuracy of the FreeStyle Libre is comparable to currently available real‐time continuous glucose monitors in adults, children and during pregnancy; the cost of the FreeStyle Libre is lower. Glucose data can be visualized in multiple devices and platforms, and summarized in an ambulatory glucose profile to aid pattern recognition and insulin dose adjustment. There is a need for appropriate education, of both users and healthcare professionals, to harness the full benefits. Further randomized studies to assess the long‐term impact on HbA1c, particularly in those with high baseline HbA1c and in specific age groups, such as adolescents and young adults, are warranted. The potential impact on complications, is yet to be realized.Keywords
This publication has 34 references indexed in Scilit:
- International Consensus on Use of Continuous Glucose MonitoringDiabetes Care, 2017
- Adherence of self-monitoring of blood glucose in persons with type 1 diabetes in SwedenBMJ Open Diabetes Research & Care, 2017
- Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin InjectionsJAMA, 2017
- Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin InjectionsJAMA, 2017
- Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trialThe Lancet, 2016
- The relationship between the frequency of self‐monitoring of blood glucose and glycemic control in patients with type 1 diabetes mellitus on continuous subcutaneous insulin infusion or on multiple daily injectionsJournal of Diabetes Investigation, 2015
- Type 1 diabetesThe Lancet, 2006
- Factors Associated With Adherence to Self-Monitoring of Blood Glucose Among Persons With DiabetesThe Diabetes Educator, 2004
- What's ahead in glucose monitoring?Postgraduate Medicine, 2001
- HOME MONITORING OF BLOOD-GLUCOSEThe Lancet, 1978